@FiercePharma: Pfizer's still working with Nestle and Danone in nutrition-unit sale, Bloomberg says, though Danone thinks it won't win. Article | Follow @FiercePharma
> After a safety review, European regulators are expected to allow the Novartis ($NVS) multiple sclerosis pill Gilenya to remain on the market without significantly stricter warnings; a decision could come this week. Story
> The U.K.'s cost-effectiveness watchdog declined to recommend Roche's ($RHHBY) Avastin as a first-line treatment for metastatic breast cancer. News
> Canada's Supreme ourt is set to hear a challenge to Pfizer's ($PFE) Viagra patent from generics maker Teva ($TEVA). More
> CSL Biotherapies pulled six batches of Albumex on contamination problems, while Hospira recalled one lot of morphine injection because of overfilled syringes. Item
> Teva Pharmaceutical Industries won an appeal in a patent fight over the branded drug Amrix that the Israeli drugmaker acquired in its Cephalon buyout. Report
> Prescription drug spending growth slowed slightly last year as new generics hit the market, Express Scripts said. Article
Biotech News
@FierceBiotech: Fierce's Top 10 Late-Stage Cancer Drugs -- 2012. Report | Follow @FierceBiotech
@JohnCFierce: GSK doubles down on drug discovery collaboration with FivePrime, a Fierce 15 company in 2004. News | Follow @JohnCFierce
@RyanMFierce: Google VC fuels Series A round for pharma software startup Wingu, aims to capitalize on open R&D trend. Story | Follow @RyanMFierce
> Abbott touts positive Parkinson's PhIII as pharma split looms. More
> Crucell and Royal DSM pull the plug on biosimilar JV. News
> J&J and Bristol-Myers ally on another potential hep C blockbuster. Article
> Roche says it won't extend Illumina offer past Friday deadline. Item
Medical Devices News
@FierceMedDev: Abbott Breakup Plans Are on Target as Profit Tops Estimates | Bloomberg. Article | Follow @FierceMedDev
> As tax looms, device companies mull layoffs, cuts. More
> St. Jude Medical ekes out Q1 sales increase. Story
Drug Delivery News
> Meet the new editor of FierceDrugDelivery. Item
> Novo: Delivery devices could make biosimilars unsafe. More
> Dutch firm gets Fox Foundation funding for PD tech. Story
> BDSI gets patent for anti-opioid film. News
> pSivida stock rallies after Durasert partnerships. Article
Biomarkers News
> Saliva test could aid dentists in oral cancer diagnosis. Story
> RNA markers for blast-induced traumatic brain injury. Item
> Postmenopausal osteoporosis fingerprinted by miRNAs. More
> Chemo-resistance proteins mark defiant breast tumors. Article
And Finally... Brain scans may be able to predict weight gain based on responses to appetite-driven cues. Report